Universal-Beteiligungs- und Servicegesellschaft
CRNX

Universal-Beteiligungs- und Servicegesellschaft’s Crinetics Pharmaceuticals CRNX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Sell
373,910
-51,706
-12% -$1.92M 0.02% 530
2026
Q1 		$15.5M Buy
425,616
+17,304
+4% +$773K 0.03% 465
2025
Q4 		$19M Buy
408,312
+20,387
+5% +$908K 0.03% 405
2025
Q3 		$16.2M Buy
387,925
+46,220
+14% +$1.48M 0.03% 449
2025
Q2 		$9.83M Sell
341,705
-1,029
-0.3% -$31.8K 0.02% 585
2025
Q1 		$11.5M Buy
342,734
+7,951
+2% +$297K 0.02% 526
2024
Q4 		$17.1M Buy
+334,783
New +$18.7M 0.03% 397

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CRNX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Crinetics Pharmaceuticals (CRNX) stake by 12% in Q2 2026, selling an estimated $1.92M and leaving 373,910 shares worth $14M. The position accounts for 0.02% of the portfolio, ranked #530.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CRNX in Q4 2024 and has held it in 7 quarters since. The position peaked at $19M in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 373,910 shares of Crinetics Pharmaceuticals worth $14M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 51,706 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $1.92M.
  • Crinetics Pharmaceuticals made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #530 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Crinetics Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Crinetics Pharmaceuticals position peaked at $19M in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.